title: Defibrotide.
abstract: Each month, subscribers toThe Formulary Monograph Servicereceive 5 to 6 well-documented monographs on drugs that are newly released or are in late phase 3 trials. The monographs are targeted to Pharmacy & Therapeutics Committees. Subscribers also receive monthly 1-page summary monographs on agents that are useful for agendas and pharmacy/nursing in-services. A comprehensive target drug utilization evaluation/medication use evaluation (DUE/MUE) is also provided each month. With a subscription, the monographs are are available online to subscribers. Monographs can be customized to meet the needs of a facility. Through the cooperation ofThe Formulary, Hospital Pharmacypublishes selected reviews in this column. For more information aboutThe Formulary Monograph Service, contact Wolters Kluwer customer service at 866-397-3433. The November 2016 monograph topics are apaziquone, crisaborole, irinotecan liposome, plecanatide, and telotristat. The Safety MUE is on methylnaltrexone PO.
authors.forename: Danial E
authors.initials: DE
authors.lastname: Baker
authors.forename: Kendra
authors.initials: K
authors.lastname: Demaris